Amy Tishelman

Dr. Amy Tishelman


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2019 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
ATAmy Tishelman
Amy Tishelman
MSMegan E. Sutter
Megan E. Sutter
DCDiane Chen
Diane Chen
ASAmani Sampson
Amani Sampson
LNLeena Nahata
Leena Nahata
GQGwendolyn Quinn
Gwendolyn Quinn

9 July 2019 in JMIR Research Protocols
Verified
Journal Article
Open access
JOJohanna Olson-Kennedy
Johanna Olson-Kennedy
YCYee-Ming Chan
Yee-Ming Chan
Robert GarofaloRobert Garofalo
Robert Garofalo
NSNorman Spack
Norman Spack
DCDiane Chen
Diane Chen
SRStephen Rosenthal
Stephen Rosenthal
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Transgender children and adolescents, those who experience incongruence between assigned sex at birth and internal gender identity, are a poorly understood and understudied population in the United States. Since 2008, medical care for transgender youth has generally followed guidelines developed by professional consensus given the paucity of empirical research, particularly in a U.S. setting. Objective: The objective of this research is to provide evidence-based data to inform clinical care for transgender youth. The study aims to: 1) evaluate the impact of gonadotropin-releasing hormone (GnRH) agonists administered for puberty suppression on mental health, psychological well-being, and metabolic and physiologic parameters including bone health in a cohort of children and adolescents (Tanner stages 2-4) with gender dysphoria, comparing baseline and follow-up assessments; and 2) evaluate the impact of gender-affirming hormones (e.g. estradiol, testosterone, etc.) administered for phenotypic gender transition on mental health, psychological well-being, and metabolic and physiologic parameters in a cohort of adolescents with gender dysphoria, comparing baseline and follow-up assessments. Methods: The study uses a longitudinal observational design to examine the outcomes of existing medical treatment protocols for gender dysphoria in two distinct cohorts: youth initiating puberty suppression and youth pursuing a phenotypic gender transition. Routine anthropometric and physiologic parameters are collected through chart abstraction, questionnaires, and research interviews throughout the 24-month study period. Audio computer-assisted self-interview (ACASI) and individual interview survey instruments are used to collect demographic, mental health, psychosocial, and behavioral data from parents and youth in the blocker cohort and only from youth in the gender-affirming hormone cohort at baseline, 6, 12, 18, and 24 months. Results: Participant recruitment commenced in July 2016 and enrollment was completed in September 2018. Ninety participants were enrolled in the blocker cohort, and 301 participants in the gender affirming hormone cohort. Findings based on baseline data are expected to be submitted for publication in 2019. Results: Participant recruitment commenced in July 2016 and enrollment was completed in September 2018. Ninety participants were enrolled in the blocker cohort, and 301 participants in the gender affirming hormone cohort. Findings based on baseline data are expected to be submitted for publication in 2019. Conclusions: This longitudinal, observational study is collecting critical data on the existing models of care for transgender youth that have been used in clinical settings for close to a decade, though with limited empirical research to support them. This research is a direct response to the Institute of Medicine report calling for such studies, as well as the needs of clinicians and patients. Results from this study have the potential to significantly impact the medical and mental health services provided to transgender youth by making available rigorous scientific evidence describing the impact and safety of early treatment based on sexual development stage. Ultimately, we aim to understand if early medical intervention reduces the health disparities well-known to disproportionately affect transgender individuals across the lifespan.

1 January 2017 in Child Abuse & Neglect
Verified
Journal Article
Closed access
ATAmy Tishelman
Amy Tishelman
LFLisa A. Fontes
Lisa A. Fontes

26 September 2020 in Journal of Pediatric Psychology
Verified
Journal Article
Open access
PDF file
CRCaroline M Roberts
Caroline M Roberts
CSChristina M Sharkey
Christina M Sharkey
DBDana M. Bakula
Dana M. Bakula
MPMegan N Perez
Megan N Perez
ADAlexandria J Delozier
Alexandria J Delozier
LMLarry L Mullins
Larry L Mullins
A subset of parents of children with disorders/differences of sex development (DSD) including ambiguous genitalia experience clinically elevated levels of anxious and depressive symptoms. Research indicates that uncertainty about their child’s DSD is associated with parent psychosocial distress; however, previous studies have been cross-sectional or correlational in nature. The current study is the first to examine the longitudinal trajectory of the relationship between caregiver-perceived uncertainty about their child’s DSD and caregiver anxious and depressive symptoms across the first 12 months following genital surgery in young children, or if surgery was not performed, the first 12 months following study entry. One hundred and thirteen caregivers (Mage = 32.12; 57.5% mothers; 72.6% Caucasian) of children (N = 70; Mage = 9.81 months; 65.7% female) with DSD were recruited from 12 DSD specialty clinics in the United States. Caregivers completed psychosocial measures at baseline, 6 and 12 months following genitoplasty, or study entry if parents elected not to have surgery for their child. Caregiver illness uncertainty and both anxious and depressive symptoms were highest at baseline and decreased over time (ps < .05). Caregiver illness uncertainty predicted symptoms of anxious and depressive symptoms across all time points (ps < .05). Caregivers’ perceptions of uncertainty about their child’s DSD are highest soon after diagnosis, and uncertainty continues to predict both anxious and depressive symptoms across time. Thus, the initial diagnostic period is a critical time for psychological assessment and intervention, with parent illness uncertainty being an important clinical target.

1 August 2016 in Child Abuse & Neglect
Verified
Journal Article
Closed access
LFLisa A. Fontes
Lisa A. Fontes
ATAmy Tishelman
Amy Tishelman

1 December 2010 in Journal of Child & Adolescent Trauma
Verified
Journal Article
Closed access
PDF file
ATAmy Tishelman
Amy Tishelman
PHPenny Haney
Penny Haney
JOJessica Greenwald O’bRien
Jessica Greenwald O’bRien
MBMargaret E. Blaustein
Margaret E. Blaustein
Despite an increased recognition of the prevalence of exposure to traumatic stress in the lives of children, relatively little attention has been devoted to their socioemotional functioning and...